Download File

Description:

ACC.18 Presentation Slides | CVD-REAL 2: Lower Risk of CV Events and Death Associated With SGLT-2 Inhibitors vs. Glucose Lowering Drugs

Date: March 11, 2018    

Keywords: ACC18 Slides, ACC Annual Scientific Session, Primary Prevention, Diabetes Mellitus, Type 2, Glucose, Propensity Score, Glucosides, Benzhydryl Compounds, Registries, Stroke, Heart Failure, Sodium-Glucose Transport Proteins, Hospitalization